These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

388 related items for PubMed ID: 9459896

  • 1. New treatment options for CMV retinitis in AIDS.
    Lalezari JP.
    Adv Nurse Pract; 1997 Apr; 5(4):45-9, 83. PubMed ID: 9459896
    [No Abstract] [Full Text] [Related]

  • 2. Support for new foscarnet indication for AIDS-related CMV retinitis is mixed.
    AIDS Patient Care STDS; 1997 Oct; 11(5):377. PubMed ID: 11361828
    [No Abstract] [Full Text] [Related]

  • 3. Foscavir receives new indication.
    AIDS Alert; 1997 Jun; 12(6):71. PubMed ID: 11364364
    [Abstract] [Full Text] [Related]

  • 4. Therapy with a combination of intravitreal foscarnet and intravenous ganciclovir in clinically resistant cytomegalovirus retinitis and patients with acquired immunodeficiency syndrome.
    Guembel HO, Hofmann F, van Even G, Cinatl J, Makabe R.
    Ger J Ophthalmol; 1996 Nov; 5(6):490-1. PubMed ID: 9479542
    [No Abstract] [Full Text] [Related]

  • 5. Controversies in the treatment of cytomegalovirus retinitis: foscarnet versus ganciclovir.
    Jabs DA.
    Infect Agents Dis; 1995 Sep; 4(3):131-42. PubMed ID: 8548191
    [Abstract] [Full Text] [Related]

  • 6. Re-evaluation of time to progression of foscarnet salvage therapy for cytomegalovirus retinitis in AIDS patients clinically resistant to ganciclovir.
    Mueller AJ, Jacobson MA, Hurwitz S, Chuang EL, Friedberg DN, Haidt SJ, Heinemann MH, Jabs DA, Kaplan HJ, Freeman WR.
    AIDS; 1997 Mar; 11(3):397-9. PubMed ID: 9147441
    [No Abstract] [Full Text] [Related]

  • 7. Foscarnet or ganciclovir for treatment of AIDS and CMV retinitis.
    Moyle G, Gazzard BG.
    Am J Med; 1995 Mar; 98(3):319-20. PubMed ID: 7872356
    [No Abstract] [Full Text] [Related]

  • 8. Cytomegalovirus retinitis in persons with AIDS. Selecting therapy for a sight-threatening disease.
    Balfour HH.
    Postgrad Med; 1995 Jan; 97(1):109-13, 117-8. PubMed ID: 7816708
    [Abstract] [Full Text] [Related]

  • 9. Current management of cytomegalovirus retinitis in AIDS update on ganciclovir and foscarnet for CMV infections.
    Jacobson MA.
    Adv Exp Med Biol; 1996 Jan; 394():85-92. PubMed ID: 8815712
    [No Abstract] [Full Text] [Related]

  • 10. Phosphonoformate for CMV retinitis in AIDS.
    Colucciello M.
    Am J Med; 1995 Mar; 98(3):317-8. PubMed ID: 7872354
    [No Abstract] [Full Text] [Related]

  • 11. The changing treatment options for CMV retinitis.
    Gilden D.
    GMHC Treat Issues; 1995 Mar; 9(7/8):1-8. PubMed ID: 11362648
    [Abstract] [Full Text] [Related]

  • 12. A brighter future for the AIDS patient.
    Lowell E, Van Tassell B.
    Insight; 2002 Mar; 27(4):95-6. PubMed ID: 12520982
    [Abstract] [Full Text] [Related]

  • 13. The progressive outer retinal necrosis syndrome: successful treatment with combination antiviral therapy.
    Ciulla TA, Rutledge BK, Morley MG, Duker JS.
    Ophthalmic Surg Lasers; 1998 Mar; 29(3):198-206. PubMed ID: 9547773
    [Abstract] [Full Text] [Related]

  • 14. Combination foscarnet and ganciclovir therapy vs monotherapy for the treatment of relapsed cytomegalovirus retinitis in patients with AIDS. The Cytomegalovirus Retreatment Trial. The Studies of Ocular Complications of AIDS Research Group in Collaboration with the AIDS Clinical Trials Group.
    Arch Ophthalmol; 1996 Jan; 114(1):23-33. PubMed ID: 8540847
    [Abstract] [Full Text] [Related]

  • 15. Treatment of cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome.
    Jacobson MA.
    N Engl J Med; 1997 Jul 10; 337(2):105-14. PubMed ID: 9211681
    [No Abstract] [Full Text] [Related]

  • 16. Cytomegalovirus retinitis: new developments in prophylaxis and therapy.
    Jacobson MA.
    AIDS Clin Rev; 1997 Jul 10; ():249-69. PubMed ID: 9305451
    [No Abstract] [Full Text] [Related]

  • 17. [Prophylaxis secondary to retinitis by CMV in patients with AIDS: the efficacy of an intermittent schedule of 3 days/week].
    Mallolas J, Gatell JM, Gómez-Sirvent JL, Buira E, Zamora L, Alecrim-Andrade J, Adán A, Morales M, Miró JM, Lonća M, Guelar A, Soriano E.
    Enferm Infecc Microbiol Clin; 1997 Feb 10; 15(2):61-4. PubMed ID: 9101748
    [Abstract] [Full Text] [Related]

  • 18. Pharmacologic management of cytomegalovirus retinitis: review of current and future therapeutic modalities.
    Bright DC.
    J Am Optom Assoc; 1997 Jan 10; 68(1):11-30. PubMed ID: 9037986
    [Abstract] [Full Text] [Related]

  • 19. Combination therapy improves CMV treatment.
    AIDS Alert; 1996 Mar 10; 11(3):32-3. PubMed ID: 11363244
    [Abstract] [Full Text] [Related]

  • 20. Combined intravenous ganciclovir and foscarnet for children with recurrent cytomegalovirus retinitis.
    Walton RC, Whitcup SM, Mueller BU, Lewis LL, Pizzo PA, Nussenblatt RB.
    Ophthalmology; 1995 Dec 10; 102(12):1865-70. PubMed ID: 9098289
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.